CINECA IRIS Institutional Research Information System

VALDISERRA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.152
AS - Asia 1.424
EU - Europa 1.171
SA - Sud America 201
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 76
OC - Oceania 19
Totale 7.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.081
SG - Singapore 492
IT - Italia 376
CN - Cina 310
SE - Svezia 212
HK - Hong Kong 170
BR - Brasile 157
IN - India 118
DE - Germania 115
VN - Vietnam 111
GB - Regno Unito 105
FI - Finlandia 82
FR - Francia 70
JP - Giappone 63
NL - Olanda 46
CI - Costa d'Avorio 38
BG - Bulgaria 33
CA - Canada 33
TR - Turchia 27
KR - Corea 26
PL - Polonia 20
RU - Federazione Russa 20
AU - Australia 19
AT - Austria 17
MX - Messico 17
BD - Bangladesh 16
SN - Senegal 15
ID - Indonesia 14
AR - Argentina 13
IQ - Iraq 11
CZ - Repubblica Ceca 10
NG - Nigeria 10
ZA - Sudafrica 10
ES - Italia 9
IR - Iran 9
LT - Lituania 9
MA - Marocco 9
PT - Portogallo 9
SA - Arabia Saudita 9
JM - Giamaica 8
UZ - Uzbekistan 8
VE - Venezuela 8
PK - Pakistan 7
UA - Ucraina 7
CR - Costa Rica 6
EC - Ecuador 6
PE - Perù 6
EG - Egitto 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CH - Svizzera 4
CL - Cile 4
IE - Irlanda 4
JO - Giordania 4
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
AL - Albania 2
BE - Belgio 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JE - Jersey 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
RO - Romania 1
SI - Slovenia 1
SO - Somalia 1
TJ - Tagikistan 1
Totale 7.071
Salva come PNG Salva come JPEG
Città #
Ashburn 328
Singapore 286
San Jose 225
Dallas 186
Hong Kong 166
Santa Clara 166
Shanghai 94
Los Angeles 85
Munich 62
Boardman 60
Chandler 55
Atlanta 52
New York 52
Florence 51
Beijing 47
Council Bluffs 45
London 43
Tokyo 41
Pisa 40
Abidjan 38
Turku 38
Helsinki 35
Sofia 33
Ho Chi Minh City 29
Hanoi 27
Serra 27
Mumbai 26
Kent 21
Lauterbourg 21
Milan 20
Frankfurt am Main 19
Hyderabad 19
Massa 19
Princeton 19
Rome 19
Chicago 18
Fairfield 18
Istanbul 18
San Francisco 18
Hefei 16
Dakar 15
Denver 15
Lawrence 15
Washington 15
Brooklyn 14
Buffalo 14
Phoenix 14
Warsaw 13
Houston 12
Medford 12
Memphis 12
Da Nang 11
Seoul 11
São Paulo 11
Wilmington 11
Lagos 10
Orem 10
Amsterdam 9
Chennai 9
Ogden 9
Redondo Beach 9
Baltimore 8
Bengaluru 8
Fuzhou 8
Jakarta 8
Naples 8
Sassuolo 8
Tashkent 8
Johannesburg 7
Livorno 7
Queens 7
Redwood City 7
Vienna 7
Cambridge 6
Jeju City 6
Lappeenranta 6
Mexico City 6
Miami 6
Poplar 6
Roubaix 6
Toronto 6
Turin 6
Vancouver 6
Belgrade 5
Belo Horizonte 5
Buenos Aires 5
Detroit 5
Düsseldorf 5
Haiphong 5
Manchester 5
Marseille 5
Montreal 5
New Malden 5
Nuremberg 5
Paris 5
Philadelphia 5
Prague 5
Pristina 5
Quanzhou 5
Rio de Janeiro 5
Totale 3.069
Salva come PNG Salva come JPEG
Nome #
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 845
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 372
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 315
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 295
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 266
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 255
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 238
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 224
Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling 214
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 202
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 201
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 199
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 188
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 184
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 179
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 177
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 164
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 157
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 154
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 145
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 144
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 143
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 140
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 137
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 136
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 134
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 133
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 129
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 123
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 122
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 120
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 118
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 114
Communicating Drug Safety 95
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 87
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 83
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 69
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 59
Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging 31
The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives 28
Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study 23
Totale 7.142
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022322 0 0 54 60 55 24 15 12 15 9 22 56
2022/2023373 59 81 30 17 21 24 22 5 77 0 37 0
2023/2024407 3 11 23 3 30 46 58 36 32 26 67 72
2024/20251.574 34 64 85 132 99 159 159 58 160 171 186 267
2025/20262.580 163 137 216 189 208 105 300 69 170 189 743 91
2026/20271.852 294 1.470 88 0 0 0 0 0 0 0 0 0
Totale 7.142